Literature DB >> 12352009

Arterial retention of apolipoprotein B(48)- and B(100)-containing lipoproteins in atherogenesis.

Spencer D Proctor1, Donna F Vine, John C L Mamo.   

Abstract

PURPOSE OF REVIEW: The "response to retention" hypothesis of atherosclerosis suggests that the arterial deposition of cholesterol is directly proportional to the concentration of circulating plasma lipoproteins. However, there is increasing evidence to support the concept that specific lipoproteins may be preferentially retained within the arterial wall, possibly as a result of greater affinity for cell surface and extracellular matrices. RECENT
FINDINGS: Recently, key studies have provided insight into mechanisms involved in the interaction of apolipoprotein B (apoB)-containing lipoproteins with extracellular matrices. In addition, novel methods and innovative experimental design has enabled us to differentiate between the delivery, retention and efflux of apoB(48)- and apoB(100)-containing lipoproteins. Other studies have demonstrated a relationship between extracellular matrix proteoglycan expression and the development of atherosclerosis. Discussion in the present review also extends to the mechanisms that are involved in the relative intimal retention of apoB(48)- and apoB(100)-containing lipoproteins in order to explain the atherogenicity of these macromolecules.
SUMMARY: The perspective of this review is to highlight recent advances in the area of arterial lipoprotein retention and the physiological significance these processes may have in the aetiology of cardiovascular disease. Importantly, an understanding of the mechanisms responsible for the retention of apoB(48)/B(100)-containing lipoproteins will enable new strategies to be developed for the future management of cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12352009     DOI: 10.1097/00041433-200210000-00001

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  40 in total

Review 1.  Dietary factors in atherogenesis.

Authors:  Margaret-Mary G Wilson; David R Thomas
Journal:  Curr Atheroscler Rep       Date:  2003-07       Impact factor: 5.113

2.  Type 2 diabetes in mice induces hepatic overexpression of sulfatase 2, a novel factor that suppresses uptake of remnant lipoproteins.

Authors:  Keyang Chen; Ming-Lin Liu; Lana Schaffer; Mingzhen Li; Guenther Boden; Xiangdong Wu; Kevin Jon Williams
Journal:  Hepatology       Date:  2010-11-03       Impact factor: 17.425

3.  Regulating intestinal function to reduce atherogenic lipoproteins.

Authors:  M Mahmood Hussain; Tung Ming Leung; Liye Zhou; Sarah Abu-Merhi
Journal:  Clin Lipidol       Date:  2013-08-01

Review 4.  Does Dietary Cholesterol Matter?

Authors:  Scott M Grundy
Journal:  Curr Atheroscler Rep       Date:  2016-11       Impact factor: 5.113

Review 5.  Atherosclerotic cardiovascular disease: a review of initiators and protective factors.

Authors:  Mohammed S Ellulu; Ismail Patimah; Huzwah Khaza'ai; Asmah Rahmat; Yehia Abed; Faisal Ali
Journal:  Inflammopharmacology       Date:  2016-01-11       Impact factor: 4.473

6.  Effects of CETP inhibition on triglyceride-rich lipoprotein composition and apoB-48 metabolism.

Authors:  Margaret R Diffenderfer; Margaret E Brousseau; John S Millar; P Hugh R Barrett; Chorthip Nartsupha; Peter M Schaefer; Megan L Wolfe; Gregory G Dolnikowski; Daniel J Rader; Ernst J Schaefer
Journal:  J Lipid Res       Date:  2012-04-02       Impact factor: 5.922

7.  Triacylglycerol-rich lipoproteins derived from healthy donors fed different olive oils modulate cytokine secretion and cyclooxygenase-2 expression in macrophages: the potential role of oleanolic acid.

Authors:  V S Graham; C Lawson; C P D Wheeler-Jones; J S Perona; V Ruiz-Gutierrez; K M Botham
Journal:  Eur J Nutr       Date:  2011-06-17       Impact factor: 5.614

8.  The relative atherogenicity of VLDL and LDL is dependent on the topographic site.

Authors:  Eline Van Craeyveld; Frank Jacobs; Yingmei Feng; Leen C J Thomassen; Johan A Martens; Joke Lievens; Jan Snoeys; Bart De Geest
Journal:  J Lipid Res       Date:  2010-01-19       Impact factor: 5.922

9.  Postprandial lipoproteins and cardiovascular disease risk in diabetes mellitus.

Authors:  Byambaa Enkhmaa; Zeynep Ozturk; Erdembileg Anuurad; Lars Berglund
Journal:  Curr Diab Rep       Date:  2010-02       Impact factor: 4.810

10.  Suppression of nuclear factor-kappaB activity in macrophages by chylomicron remnants: modulation by the fatty acid composition of the particles.

Authors:  Clara De Pascale; Valerie Graham; Robert C Fowkes; Caroline P D Wheeler-Jones; Kathleen M Botham
Journal:  FEBS J       Date:  2009-09-02       Impact factor: 5.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.